Search by Drug Name or NDC

    NDC 71428-0003-60 Clindamycin Phosphate 10 mg/mL Details

    Clindamycin Phosphate 10 mg/mL

    Clindamycin Phosphate is a TOPICAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glasshouse Pharmaceuticals Limited Canada. The primary component is CLINDAMYCIN.

    Product Information

    NDC 71428-0003
    Product ID 71428-003_0e88c0f2-16c1-3684-e063-6394a90a12d0
    Associated GPIs 90051010102005
    GCN Sequence Number 007727
    GCN Sequence Number Description clindamycin phosphate SOLUTION 1 % TOPICAL
    HIC3 Q5W
    HIC3 Description TOPICAL ANTIBIOTICS
    GCN 31720
    HICL Sequence Number 004045
    HICL Sequence Number Description CLINDAMYCIN PHOSPHATE
    Brand/Generic Generic
    Proprietary Name Clindamycin Phosphate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Clindamycin Phosphate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route TOPICAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/mL
    Substance Name CLINDAMYCIN
    Labeler Name Glasshouse Pharmaceuticals Limited Canada
    Pharmaceutical Class Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209846
    Listing Certified Through 2025-12-31

    Package

    NDC 71428-0003-60 (71428000360)

    NDC Package Code 71428-003-60
    Billing NDC 71428000360
    Package 1 BOTTLE in 1 CARTON (71428-003-60) / 60 mL in 1 BOTTLE
    Marketing Start Date 2019-03-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.18199
    Pricing Unit ML
    Effective Date 2022-11-23
    NDC Description CLINDAMYCIN PH 1% SOLUTION
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis